XETRA - Delayed Quote EUR
Biotest Aktiengesellschaft (BIO3.DE)
30.20
0.00
(0.00%)
At close: April 25 at 5:36:24 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
60,900
60,900
-2,700
-40,500
33,900
Investing Cash Flow
-25,700
-25,700
1,300
-37,000
-23,400
Financing Cash Flow
-35,400
-35,400
-6,800
89,600
22,600
Other Cash Adjustment Inside Change in Cash
--
--
-400
--
--
End Cash Position
107,800
107,800
108,100
116,600
104,400
Capital Expenditure
-28,700
-28,700
-33,400
-29,300
-18,200
Issuance of Debt
197,400
197,400
10,100
100,000
25,100
Repayment of Debt
-225,100
-225,100
-12,000
--
--
Free Cash Flow
32,200
32,200
-36,100
-69,800
15,700
12/31/2021 - 11/17/1998
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AYJ.DE Valneva SE
3.1560
+0.32%
88Q.DE 4basebio PLC
12.90
0.00%
NVV1.DE Novavax, Inc.
7.85
-0.53%
7V0.DE Darwin AG
27.40
0.00%
9VC.DE Atai Life Sciences N.V.
1.3155
-2.01%
VX1.DE Vertex Pharmaceuticals Incorporated
430.90
-0.29%
NP5.DE Newron Pharmaceuticals S.p.A.
7.51
-1.57%
HPHA.DE Heidelberg Pharma AG
2.8200
+1.08%
FYB.DE Formycon AG
23.05
+1.32%
0QF.DE Moderna, Inc.
24.44
+3.85%